BHCM
WGS icon

Brevan Howard Capital Management’s GeneDx Holdings WGS Stock Holding History

Brevan Howard Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$364K Buy
5,666
+3,130
+123% +$285K ﹤0.01% 1486
2025
Q4 		$330K Sell
2,536
-2,664
-51% -$366K ﹤0.01% 1319
2025
Q3 		$560K Buy
+5,200
New +$567K ﹤0.01% 1227

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Brevan Howard Capital Management's WGS Position: Q1 2026 in Review

Brevan Howard Capital Management increased its GeneDx Holdings (WGS) stake by 123% in Q1 2026, buying an estimated $285K and bringing the position to 5,666 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

Brevan Howard Capital Management first reported a position in WGS in Q3 2025 and has held it in 3 quarters since. The position peaked at $560K in Q3 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Brevan Howard Capital Management held 5,666 shares of GeneDx Holdings worth $364K as of Q1 2026.
  • Brevan Howard Capital Management bought 3,130 GeneDx Holdings shares in Q1 2026, an estimated $285K.
  • GeneDx Holdings made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1486 holding.
  • Brevan Howard Capital Management first reported a position in GeneDx Holdings in Q3 2025 and has held it in 3 quarters since.
  • Brevan Howard Capital Management's GeneDx Holdings position peaked at $560K in Q3 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.